(Press-News.org) Engineers at the University of California, San Diego have invented a "nanosponge" capable of safely removing a broad class of dangerous toxins from the bloodstream – including toxins produced by MRSA, E. coli, poisonous snakes and bees. These nanosponges, which thus far have been studied in mice, can neutralize "pore-forming toxins," which destroy cells by poking holes in their cell membranes. Unlike other anti-toxin platforms that need to be custom synthesized for individual toxin type, the nanosponges can absorb different pore-forming toxins regardless of their molecular structures. In a study against alpha-haemolysin toxin from MRSA, pre-innoculation with nanosponges enabled 89 percent of mice to survive lethal doses.
Administering nanosponges after the lethal dose led to 44 percent survival.
The team, led by nanoengineers at the UC San Diego Jacobs School of Engineering, published the findings in Nature Nanotechnology April 14.
"This is a new way to remove toxins from the bloodstream," said Liangfang Zhang, a nanoengineering professor at the UC San Diego Jacobs School of Engineering and the senior author on the study. "Instead of creating specific treatments for individual toxins, we are developing a platform that can neutralize toxins caused by a wide range of pathogens, including MRSA and other antibiotic resistant bacteria," said Zhang. The work could also lead to non-species-specific therapies for venomous snake bites and bee stings, which would make it more likely that health care providers or at-risk individuals will have life-saving treatments available when they need them most.
The researchers are aiming to translate this work into approved therapies. "One of the first applications we are aiming for would be an anti-virulence treatment for MRSA. That's why we studied one of the most virulent toxins from MRSA in our experiments," said "Jack" Che-Ming Hu, the first author on the paper. Hu, now a post-doctoral researcher in Zhang's lab, earned his Ph.D. in bioengineering from UC San Diego in 2011.
Aspects of this work will be presented April 18 at Research Expo, the annual graduate student research and networking event of the UC San Diego Jacobs School of Engineering.
Nanosponges as Decoys
In order to evade the immune system and remain in circulation in the bloodstream, the nanosponges are wrapped in red blood cell membranes. This red blood cell cloaking technology was developed in Liangfang Zhang's lab at UC San Diego. The researchers previously demonstrated that nanoparticles disguised as red blood cells could be used to deliver cancer-fighting drugs directly to a tumor. Zhang also has a faculty appointment at the UC San Diego Moores Cancer Center.
VIDEO:
Engineers at the University of California, San Diego have invented a “nanosponge” capable of safely removing a broad class of dangerous toxins from the bloodstream -- including toxins produced by...
Click here for more information.
Red blood cells are one of the primary targets of pore-forming toxins. When a group of toxins all puncture the same cell, forming a pore, uncontrolled ions rush in and the cell dies.
The nanosponges look like red blood cells, and therefore serve as red blood cell decoys that collect the toxins. The nanosponges absorb damaging toxins and divert them away from their cellular targets. The nanosponges had a half-life of 40 hours in the researchers' experiments in mice. Eventually the liver safely metabolized both the nanosponges and the sequestered toxins, with the liver incurring no discernible damage.
Each nanosponge has a diameter of approximately 85 nanometers and is made of a biocompatible polymer core wrapped in segments of red blood cells membranes.
Zhang's team separates the red blood cells from a small sample of blood using a centrifuge and then puts the cells into a solution that causes them to swell and burst, releasing hemoglobin and leaving RBC skins behind. The skins are then mixed with the ball-shaped nanoparticles until they are coated with a red blood cell membrane.
Just one red blood cell membrane can make thousands of nanosponges, which are 3,000 times smaller than a red blood cell. With a single dose, this army of nanosponges floods the blood stream, outnumbering red blood cells and intercepting toxins.
Based on test-tube experiments, the number of toxins each nanosponge could absorb depended on the toxin. For example, approximately 85 alpha-haemolysin toxin produced by MRSA, 30 stretpolysin-O toxins and 850 melittin monomoers, which are part of bee venom.
In mice, administering nanosponges and alpha-haemolysin toxin simultaneously at a toxin-to-nanosponge ratio of 70:1 neutralized the toxins and caused no discernible damage.
One next step, the researchers say, is to pursue clinical trials.
INFORMATION:
The research was funded by the National Science Foundation (DMR-1216461) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK095168).
Nanosponges soak up toxins released by bacterial infections and venom
2013-04-15
ELSE PRESS RELEASES FROM THIS DATE:
Cutting specific pollutants would slow sea level rise
2013-04-15
BOULDER – With coastal areas bracing for rising sea levels, new research indicates that cutting emissions of certain pollutants can greatly slow down sea level rise this century.
The research team found that reductions in four pollutants that cycle comparatively quickly through the atmosphere could temporarily forestall the rate of sea level rise by roughly 25 to 50 percent.
"To avoid potentially dangerous sea level rise, we could cut emissions of short-lived pollutants even if we cannot immediately cut carbon dioxide emissions," says Aixue Hu of the National Center ...
Mount Sinai study identifies new gene variations associated with heart rate
2013-04-15
(New York, NY – April 14, 2013) – Through a collaborative genome-wide study on individuals, researchers have discovered 14 new genetic variations that are associated with heart rate. Since heart rate is a marker of cardiovascular health, these findings could provide a better understanding of genetic regulation of heart beat and is a first step towards identifying targets for new drugs to treat cardiovascular disease.
The study, titled, "Identification of Heart Rate-Associated Loci and Their Effects on Cardiac Conduction and Rhythm Disorders," was published online this ...
Recent climate, glacier changes in Antarctica at the 'upper bound' of normal
2013-04-15
In the last few decades, glaciers at the edge of the icy continent of Antarctica have been thinning, and research has shown the rate of thinning has accelerated and contributed significantly to sea level rise.
New ice core research suggests that, while the changes are dramatic, they cannot be attributed with confidence to human-caused global warming, said Eric Steig, a University of Washington professor of Earth and space sciences.
Previous work by Steig has shown that rapid thinning of Antarctic glaciers was accompanied by rapid warming and changes in atmospheric ...
Bacterial security agents go rogue
2013-04-15
CRISPR, a system of genes that bacteria use to defend themselves against viruses, has been found to be involved in helping some bacteria evade the mammalian immune system.
The results are scheduled for publication Sunday, April 14 in Nature.
CRISPR is itself a sort of immune system for bacteria. Its function was discovered by dairy industry researchers seeking to prevent phages, the viruses that infect bacteria, from ruining the cultures used to make cheese and yogurt. Bacteria incorporate small bits of DNA from phages into their CRISPR region and use that information ...
Gene sequencing project finds new mutations to blame for a majority of brain tumor subtype
2013-04-15
The St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a high toll on patients. Researchers also found evidence the tumors are susceptible to drugs already in development.
The study focused on a family of brain tumors known as low-grade gliomas (LGGs). These slow-growing cancers are found in about 700 children annually in the U.S., making them the most common childhood tumors of the brain and spinal cord. For patients whose ...
The tulip tree reveals mitochondrial genome of ancestral flowering plant
2013-04-15
The extraordinary level of conservation of the tulip tree (Liriodendron tulipifera) mitochondrial genome has redefined our interpretation of evolution of the angiosperms (flowering plants), finds research in biomed Central's open access journal BMC Biology. This beautiful 'molecular fossil' has a remarkably slow mutation rate meaning that its mitochondrial genome has remained largely unchanged since the dinosaurs were roaming the earth.
Evolutionary studies make used of mitochondrial (powerhouse) genomes to identify maternal lineages, for example the human mitochondrial ...
Ordinary skin cells morphed into functional brain cells
2013-04-15
Researchers at Case Western Reserve School of Medicine have discovered a technique that directly converts skin cells to the type of brain cells destroyed in patients with multiple sclerosis, cerebral palsy and other so-called myelin disorders.
This discovery appears today in the journal Nature Biotechnology.
This breakthrough now enables "on demand" production of myelinating cells, which provide a vital sheath of insulation that protects neurons and enables the delivery of brain impulses to the rest of the body. In patients with multiple sclerosis (MS), cerebral palsy ...
Better batteries from waste sulfur
2013-04-15
A new chemical process can transform waste sulfur into a lightweight plastic that may improve batteries for electric cars, reports a University of Arizona-led team. The new plastic has other potential uses, including optical uses.
The team has successfully used the new plastic to make lithium-sulfur batteries.
"We've developed a new, simple and useful chemical process to convert sulfur into a useful plastic," lead researcher Jeffrey Pyun said.
Next-generation lithium-sulfur, or Li-S, batteries will be better for electric and hybrid cars and for military uses because ...
Standard CT protocol for trauma patients leads to overutilization of imaging
2013-04-15
It is unnecessary to scan trauma patients based on a non-focused standard trauma CT protocol, if the patient is transferred for care after already undergoing a focused CT examination based on the patient's history and physical examination, a new study shows.
The study, conducted at the University of Pittsburgh Medical Center reviewed the records of 100 patients who were transferred from another facility. "The standard trauma CT protocol for all level 1 and 2 trauma patients transferred to our facility includes a CT examination of the head, cervical spine, thoracic spine, ...
Picture this: A dramatic drop in wrong patient errors
2013-04-15
Adding a photo of a face to x-ray images can reduce "wrong-patient" errors five-fold, a new study finds.
"X-rays can look alike, and if one patient's images are confused with another before the radiologist sees them, it can be difficult for the radiologist to determine there is a mismatch," said Dr. Srini Tridandapani, of Emory University and an author of the study.
As part of the study, ten radiologists interpreted 20 pairs of radiographic images with and without photographs. Two to four mismatched pairs were included in each set of 20 pairs of images. When photographs ...